Drug Profile
GIGA 2050
Alternative Names: GIGA-2050; rCIG; Recombinant anti-coronavirus 19 hyperimmune gammaglobulin; Recombinant anti-coronavirus 19 hyperimmune gammaglobulin therapy - GiaGen; Recombinant polyclonal antibodies - GigaGen; Recombinant polyclonal antibody therapy - GigaGenLatest Information Update: 07 Nov 2022
Price :
$50
*
At a glance
- Originator GigaGen
- Class Antivirals; Polyclonal antibodies
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I COVID 2019 infections